166 related articles for article (PubMed ID: 28964448)
1. An Experience-Based Value Set for the EQ-5D-5L in Germany.
Leidl R; Reitmeir P
Value Health; 2017 Sep; 20(8):1150-1156. PubMed ID: 28964448
[TBL] [Abstract][Full Text] [Related]
2. Experience-Based Swedish TTO and VAS Value Sets for EQ-5D-5L Health States.
Burström K; Teni FS; Gerdtham UG; Leidl R; Helgesson G; Rolfson O; Henriksson M
Pharmacoeconomics; 2020 Aug; 38(8):839-856. PubMed ID: 32307663
[TBL] [Abstract][Full Text] [Related]
3. Effect of Health State Sampling Methods on Model Predictions of EQ-5D-5L Values: Small Designs Can Suffice.
Yang Z; Luo N; Bonsel G; Busschbach J; Stolk E
Value Health; 2019 Jan; 22(1):38-44. PubMed ID: 30661632
[TBL] [Abstract][Full Text] [Related]
4. Less Is More: Cross-Validation Testing of Simplified Nonlinear Regression Model Specifications for EQ-5D-5L Health State Values.
Rand-Hendriksen K; Ramos-Goñi JM; Augestad LA; Luo N
Value Health; 2017; 20(7):945-952. PubMed ID: 28712624
[TBL] [Abstract][Full Text] [Related]
5. A hybrid modelling approach for eliciting health state preferences: the Portuguese EQ-5D-5L value set.
Ferreira PL; Antunes P; Ferreira LN; Pereira LN; Ramos-Goñi JM
Qual Life Res; 2019 Dec; 28(12):3163-3175. PubMed ID: 31201730
[TBL] [Abstract][Full Text] [Related]
6. Comparison of different valuation methods for population health status measured by the EQ-5D in three European countries.
Bernert S; Fernández A; Haro JM; König HH; Alonso J; Vilagut G; Sevilla-Dedieu C; de Graaf R; Matschinger H; Heider D; Angermeyer MC;
Value Health; 2009; 12(5):750-8. PubMed ID: 19490564
[TBL] [Abstract][Full Text] [Related]
7. A value set for the EQ-5D based on experienced health states: development and testing for the German population.
Leidl R; Reitmeir P
Pharmacoeconomics; 2011 Jun; 29(6):521-34. PubMed ID: 21247225
[TBL] [Abstract][Full Text] [Related]
8. Comparison of Value Set Based on DCE and/or TTO Data: Scoring for EQ-5D-5L Health States in Japan.
Shiroiwa T; Ikeda S; Noto S; Igarashi A; Fukuda T; Saito S; Shimozuma K
Value Health; 2016; 19(5):648-54. PubMed ID: 27565282
[TBL] [Abstract][Full Text] [Related]
9. Estimating an EQ-5D-5L Value Set for China.
Luo N; Liu G; Li M; Guan H; Jin X; Rand-Hendriksen K
Value Health; 2017 Apr; 20(4):662-669. PubMed ID: 28408009
[TBL] [Abstract][Full Text] [Related]
10. Selecting Health States for EQ-5D-3L Valuation Studies: Statistical Considerations Matter.
Yang Z; Luo N; Bonsel G; Busschbach J; Stolk E
Value Health; 2018 Apr; 21(4):456-461. PubMed ID: 29680103
[TBL] [Abstract][Full Text] [Related]
11. 3125 steps to perfect health: a nonparametric approach to developing the EQ-5D-5L value set.
Thomas S; Johnson JA; Xie F
Qual Life Res; 2020 Nov; 29(11):3109-3118. PubMed ID: 32705459
[TBL] [Abstract][Full Text] [Related]
12. Health-related quality of life measured with the EQ-5D-5L: estimation of normative index values based on a representative German population sample and value set.
Grochtdreis T; Dams J; König HH; Konnopka A
Eur J Health Econ; 2019 Aug; 20(6):933-944. PubMed ID: 31030292
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of EuroQol Valuation Technology (EQ-VT) Designs to Generate National Value Sets: Learnings from the Development of an EQ-5D Value Set for India Using an Extended Design (DEVINE) Study.
Jyani G; Yang Z; Sharma A; Goyal A; Stolk E; Purba FD; Grover S; Kaur M; Prinja S
Med Decis Making; 2023 Aug; 43(6):692-703. PubMed ID: 37480281
[TBL] [Abstract][Full Text] [Related]
14. Interim scoring for the EQ-5D-5L: mapping the EQ-5D-5L to EQ-5D-3L value sets.
van Hout B; Janssen MF; Feng YS; Kohlmann T; Busschbach J; Golicki D; Lloyd A; Scalone L; Kind P; Pickard AS
Value Health; 2012; 15(5):708-15. PubMed ID: 22867780
[TBL] [Abstract][Full Text] [Related]
15. Overview, Update, and Lessons Learned From the International EQ-5D-5L Valuation Work: Version 2 of the EQ-5D-5L Valuation Protocol.
Stolk E; Ludwig K; Rand K; van Hout B; Ramos-Goñi JM
Value Health; 2019 Jan; 22(1):23-30. PubMed ID: 30661630
[TBL] [Abstract][Full Text] [Related]
16. How Prevalent Are Implausible EQ-5D-5L Health States and How Do They Affect Valuation? A Study Combining Quantitative and Qualitative Evidence.
Yang Z; Feng Z; Busschbach J; Stolk E; Luo N
Value Health; 2019 Jul; 22(7):829-836. PubMed ID: 31277831
[TBL] [Abstract][Full Text] [Related]
17. Interim EQ-5D-5L Value Set for Poland: First Crosswalk Value Set in Central and Eastern Europe.
Golicki D; Niewada M; Hout BV; Janssen MF; Pickard AS
Value Health Reg Issues; 2014 Sep; 4():19-23. PubMed ID: 29702801
[TBL] [Abstract][Full Text] [Related]
18. Bayesian Models with Spatial Correlation Improve the Precision of EQ-5D-5L Value Sets.
Che M; Xie F; Thomas S; Pullenayegum E
Med Decis Making; 2023 Jul; 43(5):587-594. PubMed ID: 37243474
[TBL] [Abstract][Full Text] [Related]
19. Does the Introduction of the Ranking Task in Valuation Studies Improve Data Quality and Reduce Inconsistencies? The Case of the EQ-5D-5L.
Ramos-Goñi JM; Rand-Hendriksen K; Pinto-Prades JL
Value Health; 2016 Jun; 19(4):478-86. PubMed ID: 27325340
[TBL] [Abstract][Full Text] [Related]
20. An EQ-5D-5L value set based on Uruguayan population preferences.
Augustovski F; Rey-Ares L; Irazola V; Garay OU; Gianneo O; Fernández G; Morales M; Gibbons L; Ramos-Goñi JM
Qual Life Res; 2016 Feb; 25(2):323-333. PubMed ID: 26242249
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
